5.43
price up icon1.31%   0.07
after-market 시간 외 거래: 5.43
loading

Astria Therapeutics Inc 주식(ATXS)의 최신 뉴스

pulisher
Jun 18, 2025

(ATXS) Trading Report - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit - BioSpace

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innov - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Astria CEO Discusses Breakthrough Dermatology Treatments at Major Oppenheimer Summit - Stock Titan

Jun 18, 2025
pulisher
Jun 15, 2025

HC Wainwright Reaffirms “Buy” Rating for Astria Therapeutics (NASDAQ:ATXS) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $30.00 - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Astria Therapeutics (ATXS) Receives Reiterated Buy Rating and $1 - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Astria Therapeutics (ATXS) Reports Promising Results for Navenib - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Announces Positive Initial Results from the - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Says New Data Back Navenibart Dose Regimen for Hereditary Angioedema - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Increases Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 2,042 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Astria Therapeutics Stockholders Approve Key Amendments - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates ATXS FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress - BioSpace

Jun 09, 2025
pulisher
Jun 06, 2025

(ATXS) Investment Report - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Astria Therapeutics to Present at Upcoming European Academy of A - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress | ATXS Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 05, 2025

Jane Street Group LLC Has $233,000 Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Acquires Shares of 5,572 Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Lis - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATXS Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Invests $140,000 in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 13,986 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 31, 2025
pulisher
May 29, 2025

Citizens JMP maintains $25 target on Astria Therapeutics stock By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 28, 2025

Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference - Business Wire

May 28, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Takes Position in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 26, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficien - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop | ATXS Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop - Business Wire

May 23, 2025
pulisher
May 23, 2025

Northern Trust Corp Has $4.10 Million Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 23, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Confe - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference | ATXS Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

New Clinical Data: Astria's Navenibart Cuts Hereditary Angioedema Attack Severity, Reduces Rescue Med Usage - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - New Castle News

May 22, 2025
pulisher
May 21, 2025

Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Price Target at $30.00 - Defense World

May 21, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Buys 2,878 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 18, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for ATXS - Defense World

May 18, 2025
pulisher
May 17, 2025

Wedbush Lowers Earnings Estimates for Astria Therapeutics - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Astria Therapeutics Lowered by Analyst - Defense World

May 17, 2025
pulisher
May 17, 2025

Astria Therapeutics’ (ATXS) “Overweight” Rating Reiterated at Cantor Fitzgerald - Defense World

May 17, 2025
pulisher
May 16, 2025

FMR LLC Reduces Holdings in Astria Therapeutics Inc - GuruFocus

May 16, 2025
pulisher
May 16, 2025

(ATXS) Technical Data - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Astria Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Astria Therapeutics Reports Increased Loss Amid Rising R&D Costs - TipRanks

May 15, 2025
pulisher
May 14, 2025

Analyst Reiterates Overweight Rating for ATXS with Stable Price Target | ATXS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Here's Why We're Not Too Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Situation - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Astria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update | ATXS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Astria Therapeutics (ATXS) Advances Navenibart as Groundbreaking HAE Therapy | ATXS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Astria Therapeutics (ATXS) Sees Price Target Adjustment Amid Ong - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Astria Therapeutics price target lowered to $25 from $26 at Citizens JMP - TipRanks

May 14, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):